rs9274407
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs9274407
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs6582630
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs6582630
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs3129900
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury.
|
20639878 |
2010 |
rs3129900
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury.
|
20639878 |
2010 |
rs2523822
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs2523822
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
|
21570397 |
2011 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
|
30661239 |
2019 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs2395029
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs1497546
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs1497546
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs10937275
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs10937275
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs10812428
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASDB |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs10812428
|
|
Chemical and Drug Induced Liver Injury
|
|
0.800 |
GeneticVariation
|
GWASCAT |
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
|
19483685 |
2009 |
rs7828135
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.
|
25987243 |
2016 |
rs73122578
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs72696020
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs72631567
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs6694270
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs61858823
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |
rs6139258
|
|
Chemical and Drug Induced Liver Injury
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.
|
28062682 |
2017 |
rs597480
|
|
Chemical and Drug Induced Liver Injury
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
|
28043905 |
2017 |